Contact: Katie Glenn, firstname.lastname@example.org,
WASHINGTON (Jan 21, 2021) -
The American College of Cardiology will host the annual Advancing the Cardiovascular Care of the Oncology Patient Virtual course with live sessions on Feb. 5-6, 2021 and on demand content. The course will feature cardiology and oncology experts providing clinically relevant, best practice strategies for a multidisciplinary team regarding the assessment, diagnosis and management of cardiovascular concerns for cancer patients, as well as those requiring survivorship care.
Course co-directors Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, have invited respected experts in the field to create a course covering relevant and required content for both the novice and advanced practitioner. The conference aims to provide participants with the tools needed to improve patient care in their everyday practice in this rapidly evolving field through describing the evolving advances in immunotherapy and the associated cardiotoxicity; defining cardiovascular complications in cancer patients that are specific to coronary disease, vascular disease and bleeding; applying evidence-based strategies for short- and long-term surveillance; and establishing interprofessional cardio-oncology care teams and a framework to improve overall cardiovascular care of cancer patients and survivors.
- Immune Therapy and Cardiovascular Risk
- Adult and Pediatric Cancer Survivorship: Management of Modifiable Cardiovascular Risk Factors
- All About Amyloidosis
The course will also feature on-demand content available beginning on Monday, January 25, 2021.
The following abstracts are a selection of the posters being presented. All ACC Advancing the Cardiovascular Care of the Oncology Patient abstracts are embargoed until Monday, Jan. 25, 2021 at 8 a.m. ET.
- Cardiovascular Outcomes Associated with Chemotherapy and Targeted Therapies in Adolescent and Young Adult Cancer Survivors
- Cardiovascular Risk Factors and Comorbidities in Male Breast Cancer Patients
- Risk of Cardiotoxicity with Dual Human Epidermal Receptor (HER2) Targeted Therapies in Breast Cancer
- The Association of Physical Activity, Cardiac and Patient-Reported Outcomes in HER2+ Breast Cancer Survivors During Therapy
If you would like to receive embargoed copies of these abstracts or register for media access to the conference, contact Katie Glenn at email@example.com.
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.